Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 12 months ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
HFA 23: MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring
Author(s): Jasper J Brugts Added: 1 year ago
ESC-HFA 2023 — Dr Jasper Brugts (Thoraxcenter, NL) joins us to outline the findings and summarise the take-home messages from the MONITOR-HF trial (NTR7672). MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation, irrespective of… View more

Heart Failure
HFA 24: The TELESAT Study
Author(s): Nicolas Girerd Added: 12 months ago
HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients… View more

Heart Failure

Digital Health
ESC-HFA 2023: Late-Breaking Science Video Collection
Author(s): Jasper J Brugts , Ahmad Masri , Marianna Fontana , et al Added: 1 year ago
Get the most out of the new data from, Late-breaker host, Dr Harriette Van Spall and Dr James Januzzi wrap up of the most impactful trials and studies presented at Heart Failure 2023. Delve into in-depth and critical discussions with Dr Van Spall in our thought-provoking Late-breaker Discussion series. For concise and practical take-home messages for practice and cardiovascular research… View more

Guidelines & Statements

Heart Failure
Omron logo
Omron Healthcare is a manufacturer of medical equipment for therapy and health monitoring. Our range of products includes blood pressure monitors, portable ECG, augmentation index device, respiratory therapy devices, electronic fever thermometers and body fat monitors among others. Our eco-friendly products are not only known for their high quality and performance standards, but also for their… View more
HFA 24: Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
Author(s): Michael Kiernan Added: 12 months ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure… View more

Heart Failure

Digital Health
Philip B Adamson
Job title: Medical Director
Dr Philip Adamson is Medical Director of the Oklahoma Foundation for Cardiovascular Research and founder of the Heart Failure Institute at Oklahoma Heart Hospital. Dr Adamson received his MD & master's of science in cardiovascular physiology and heart failure from the University of Oklahoma Health Sciences Center. He joined the faculty at the University of Oklahoma as a Warren Foundation… View more
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi
Author(s): Harriette Van Spall , James L Januzzi Added: 1 year ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure. Trials covered in details include: 1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy 1:42: TRACER-HF:Trientine-HCL for treatment of… View more

Guidelines & Statements

Heart Failure